Sanofi (NYSE: SNY) reported Q2 EPS of EUR1.25, EUR0.05 better than the analyst estimate of EUR1.20. Revenue for the quarter came in at EUR8.18 billion versus the consensus estimate of EUR8.36 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.